Policy Number

CAN-ST-005

Biosimilars in Oncology - Policy - NSHA CAN-ST-005

Description

This is an update to a policy directive. Oncology biosimilars are to be used in clinical practice in NSH. It determines the selection of and funding for biosimilars and reference biologics.